Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial

Journal:

The Lancet Oncology

Published:

2025-05-06

DOI:

10.1016/s1470-2045(25)00197-4

Affiliations:

34

Authors:

30

Go to article

Institutions	Authors	Share
Iridium Netwerk vzw, Belgium	2.500000	0.08
Ghent University (UGent), Belgium	2.500000	0.08
Oslo University Hospital (OUS), Norway	2.000000	0.07
AZ Groeninge, Belgium	2.000000	0.07
Geneva University Hospitals (HUG), Switzerland	1.833333	0.06
The University of Melbourne (UniMelb), Australia	1.500000	0.05
Ghent University Hospital, Belgium	1.000000	0.03
AZ Sint-Lucas, Belgium	1.000000	0.03
Bern University Hospital, Switzerland	1.000000	0.03
Institute Jules Bordet, ULB, Belgium	1.000000	0.03
Clínica IMQ Zorrotzaurre, Spain	1.000000	0.03
Hospital Universitario Ramón y Cajal, Spain	1.000000	0.03
Hospital Universitario de Navarra (HUN), Spain	1.000000	0.03
University Hospital Zurich (UHZ), Switzerland	1.000000	0.03
Hospital Universitario de La Princesa, Spain	1.000000	0.03
University Hospitals Leuven (UZ Leuven), Belgium	1.000000	0.03
European University of Madrid (UEM), Spain	1.000000	0.03
IRCCS Istituto Nazionale Tumori IRCCS-Fondazione G. Pascale, Italy	1.000000	0.03
University Hospital Basel (USB), UB, Switzerland	1.000000	0.03
La Fe University Hospital, Spain	1.000000	0.03
Bergonié Cancer Institute, France	0.500000	0.02
Icon Cancer Centre Epworth Richmond, Australia	0.500000	0.02
Humanitas University, Italy	0.500000	0.02
IRCCS Humanitas Research Hospital, Italy	0.500000	0.02
Hospital de Cruces, Spain	0.333333	0.01
BioCruces Health Research Institute, Spain	0.333333	0.01
University of the Basque Country (UPV/EHU), Spain	0.333333	0.01
Oncology Institute of Southern Switzerland (IOSI), Switzerland	0.333333	0.01
Università della Svizzera Italiana (USI), Switzerland	0.333333	0.01

Interested in Biomedical Engineering?